@article{ijhd201411A2,
author={{Gertz, Morie A. and Buadi, Francis K. and Lacy, Martha Q.},
title={Is There Still a Role for High-Dose Melphalan and Stem Cell Transplantation in the Treatment of Multiple Myeloma?},
journal={International Journal of Hematological Disorders},
volume={1},
number={1A},
pages={7--12},
year={2014},
url={http://pubs.sciepub.com/ijhd/1/1A/2},
abstract={Stem cell transplantation was demonstrated to have a survival value in the era prior to the introduction of novel agents for the treatment of multiple myeloma. It has become reasonable to begin to question the value of stem cell transplantation. In this review, we analyzed available data and ongoing trials to determine whether or not the evidence is sufficient to continue using stem cell transplantation as a primary modality for the treatment of the eligible patient with multiple myeloma.},
doi={10.12691/ijhd-1-1A-2}
publisher={Science and Education Publishing}
}